首页|复合乳酸菌肠溶胶囊增强肾衰宁胶囊对肾纤维化保护作用研究

复合乳酸菌肠溶胶囊增强肾衰宁胶囊对肾纤维化保护作用研究

扫码查看
目的 研究复合乳酸菌肠溶胶囊(LCC)增强肾衰宁胶囊(SSN)对输尿管梗阻(UUO)手术大鼠模型肾纤维化的保护作用。方法 测定LCC中乳酸菌含量,UUO手术建立大鼠肾纤维化模型并每天灌胃给药,21 d后记录终末体重并计算肾系数;生化仪检测BUN、Scr和MAU的变化;病理切片HE染色和Masson染色观察肾脏的组织形态及纤维化程度;免疫组织化学法检测肾组织中α-SMA和Col1A等蛋白表达;ELISA法检测肾组织中IL-6、TNF-α、CRP和TGF-β含量及血清中D-乳酸、内毒素和二胺氧化酶(DAO)含量;Q-PCR法检测回肠组织中ZO-1、Oc-cludin、Claudin-1和Claudin-2的mRNA表达。结果 LCC联合SSN治疗可显著降低UUO肾纤维化大鼠的肾系数,BUN、Scr以及MAU的水平,大鼠体重也显著升高;明显改善肾脏组织形态及胶原蓄积;降低α-SMA和Col1 A蛋白表达,IL-6、TNF-α、CRP、TGF-β、D-乳酸和二胺氧化酶(DAO)含量;升高 ZO-1、Occludin、Claudin-1 的 mRNA表达并降低Claudin-2的mRNA表达,最终起到改善肾纤维化的作用。结论 复合乳酸菌肠溶胶囊(LCC)可增强肾衰宁胶囊(SSN)对肾纤维化的改善作用,其作用主要与抗炎、抗纤维化、调节菌群平衡及改善肠黏膜屏障有关,依据肾-肠轴理论,为治疗肾纤维化提供了依据和新的治疗方法。
Study of the protective effect of Lactic Acid Bacteria Complex Enteric Capsules strengthen Shenshuaining Capsules on renal fibrosis
Objective To investigate the protective effect of Lactic Acid Bacteria Complex Enteric Capsules(LCC)combined with Shenshuaining Capsules(SSN)on renal fibrosis in the ureteral obstruction(UUO)surgical rat models.Meth-ods LCC were tested.The UUO surgery was performed to establish renal fibrosis model in rat models.After drug combina-tion of LCC and SSN for 21 days,terminal body weight was recorded and the renal coefficient was calculated;BUN,Scr and MAU were detected by biochemical instrument;Kidney tissue morphology and the degree of fibrosis were observed and eval-uated by HE and Masson staining;The expression of α-SMA and Col1 A in kidney tissues was determined by immunohisto-chemistry;The content of IL-6,TNF-α,CRP and TGF-β in renal tissue and the content of D-lactate,endotoxin and diam-ine oxidase(DAO)in serum were detected by ELISA;The mRNA expression of ZO-1,Occludin,Claudin-1,and Claudin-2 in the ileal tissue was determined by Q-PCR.Results Compared to SSN group,the rat models with drug combination of LCC combined with SSN treatment significantly reduced renal coefficient,BUN,Scr and MAU;Increased the body weight;Significantly improved renal tissue morphology and collagen accumulation;Decreased the expression of α-SMA and Col 1 A protein,IL-6,TNF-α,CRP,TGF-p,D-lactate and diamine oxidase(DAO);Increased mRNA expression of ZO-1,Occlu-din,Claudin-1 and decreased mRNA expression of Claudin-2,and ultimately improved renal fibrosis.Conclusion LCC can enhance the improvement of SSN on renal fibrosis,and its effect is mainly related to anti-inflammation,anti-fibrosis,regulation of microflora balance and improvement of intestinal mucosal barrier.Based on the renal-intestinal axis theory,it provides a basis and a new treatment method for the treatment of renal fibrosis.

Lactic Acid Bacteria Complex Enteric CapsulesShenshuaining CapsulesRenal fibrosis

杨昊、宋显瑞、张蕾

展开 >

江苏省食品药品监督检验研究院,江苏南京 210019

南京中医药大学,江苏南京 210000

复合乳酸菌肠溶胶囊 肾衰宁胶囊 肾纤维化

江苏省市场监督管理局科技计划项目

KJ21125094

2024

药学研究
山东省药品检验所 山东省药学会

药学研究

CSTPCD
影响因子:0.653
ISSN:2095-5375
年,卷(期):2024.43(2)
  • 16